Rendered inside a sandboxed frame: scripts, forms and links are disabled. Loading remote images may confirm to the sender that this address exists.
From localhost Sun May 24 15:36:27 2026 X-SPAM-SRC: REPO Return-Path: <4cyuqsrlrc@Kar19569723.onmicrosoft.com> Delivered-To: markus.naegeli@stafag.ch Received: from obelix.imp.ch ([157.161.12.5]) by tragicomix.imp.ch with LMTP id uE/JKUTuEmqXJDQAGLljUw:P1 (envelope-from <4cyuqsrlrc@Kar19569723.onmicrosoft.com>) for <markus.naegeli@stafag.ch>; Sun, 24 May 2026 14:25:40 +0200 Received: from obelix.imp.ch ([157.161.12.5]) by obelix.imp.ch with LMTP id uE/JKUTuEmqXJDQAGLljUw (envelope-from <4cyuqsrlrc@Kar19569723.onmicrosoft.com>) for <markus.naegeli@stafag.ch>; Sun, 24 May 2026 14:25:40 +0200 Received: from SEYPR02CU001.outbound.protection.outlook.com (mail-koreacentralazhn150130003.outbound.protection.outlook.com [IPv6:2a01:111:f403:dc0f::3]) (using TLSv1.3 with cipher TLS_AES_256_GCM_SHA384 (256/256 bits) key-exchange ECDHE (P-384) server-signature RSA-PSS (4096 bits) server-digest SHA256) (No client certificate requested) by obelix.imp.ch (Postfix) with ESMTPS id 1F479E39F4 for <markus.naegeli@stafag.ch>; Sun, 24 May 2026 14:25:29 +0200 (CEST) ARC-Seal: i=1; a=rsa-sha256; s=arcselector10001; d=microsoft.com; cv=none; b=n5123D910kt33HzVBE4n2XGfmVYUDqE7LG4r70nzSY+G4aK/zu8CIJeFyGNqM8+9jsSBPZNt171bxJVe1d8XuTreaDVFWlXx95r7DYt2uWLkCBsJ40gk9njtcR/9iLxOxc3A/pyCIlUzUT9lkDYnFS/y8+x1+vFe7cz7/Wjtu5yd5X8ZZqHtM8xDvJ7PMrtqww9o5DzhbzjGhbkx1MtI/WKJpUNHge7qPOC97mzjXFGrpaAI7K0/950t78PRryhBQbqEvk5CrF/qQA64W7mFhZ6kAKkC785EOGs9y/QjCrS5p+k4G3aueoD2XDlkhk5KuuAHhm8AqnsOpmiPSoOB0g== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector10001; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=2kxOBJDp5l6SpqBOF0TXWQGcrvQZBR5mKUVa5JHEJWA=; b=UtDszGj7RMa6VJO33QT1en8tTXlbmak9DWEj92mnaJobgfNtLCiiOCPLlv2wuN8MMTYJXNU+UbVNv11jQJQMzoS3TafHDxSIBuLFg3+d6jK/6SG/I7NTH/zYFirkptkVychsUomC8RK5pWMGF/iuwgPsSBZ1CAHDmza9/JirpnTxz1hBXWBuCHITf90BlYJ8BEjs8VkhEp0fy1HIYhXo4Npc3AqnkmI2m6bTgfPKMCCxu9VNcCOgaIxDekqVLy5qLZ1kfXxwZ1dqpmODS5fcxC0x+j99aQGGVPykCBVM+ZQUgUyaZWYSGeevrziq9rSwp6Zux4C3DVLyGhpuNRfdcg== ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=fail (sender ip is 194.37.82.176) smtp.rcpttodomain=stafag.ch smtp.mailfrom=kar19569723.onmicrosoft.com; dmarc=none action=none header.from=cnnovcp9.com; dkim=none (message not signed); arc=none (0) Received: from PS2PR03CA0020.apcprd03.prod.outlook.com (2603:1096:300:5b::32) by SEL0PFFFAECFF5E.apcprd01.prod.exchangelabs.com (2603:1096:108:1::5e3) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.48.19; Sun, 24 May 2026 12:25:24 +0000 Received: from TY2PEPF0000AB83.apcprd03.prod.outlook.com (2603:1096:300:5b:cafe::89) by PS2PR03CA0020.outlook.office365.com (2603:1096:300:5b::32) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.71.10 via Frontend Transport; Sun, 24 May 2026 12:25:24 +0000 X-MS-Exchange-Authentication-Results: spf=fail (sender IP is 194.37.82.176) smtp.mailfrom=Kar19569723.onmicrosoft.com; dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=CNNovcp9.com; Received-SPF: Fail (protection.outlook.com: domain of Kar19569723.onmicrosoft.com does not designate 194.37.82.176 as permitted sender) receiver=protection.outlook.com; client-ip=194.37.82.176; helo=Kar19569723.onmicrosoft.com; Received: from Kar19569723.onmicrosoft.com (194.37.82.176) by TY2PEPF0000AB83.mail.protection.outlook.com (10.167.253.4) with Microsoft SMTP Server id 15.21.71.7 via Frontend Transport; Sun, 24 May 2026 12:25:23 +0000 To: markus.naegeli@stafag.ch Date: Sun, 24 May 2026 12:25:22 +0000 MIME-Version: 1.0 List-Unsubscribe-Post: List-Unsubscribe=One-Click Subject: Breaking: Clinical trials confirm GLPro successLVM-427466 From: "Blood Sugar Watch" <Health@CNNovcp9.com> Content-Type: text/html; charset="UTF-8" Content-Transfer-Encoding: 8bit Message-ID: <148cbe69-bfe6-4032-b54c-4ab27f023fde@TY2PEPF0000AB83.apcprd03.prod.outlook.com> X-EOPAttributedMessage: 0 X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: TY2PEPF0000AB83:EE_|SEL0PFFFAECFF5E:EE_ X-MS-Office365-Filtering-Correlation-Id: 378a4fec-0fce-4e95-f4d5-08deb98f879e X-MS-Exchange-SenderADCheck: 2 X-MS-Exchange-AntiSpam-Relay: 0 X-Microsoft-Antispam: BCL:0;ARA:13230040|36860700016|4022899009|7149299003|82310400026|1032899013|34070700014|69100299015|48200799018|61400799027|376014|7049299003|3109299003|3122999024|8096899003|2066899003|4076899003|52005299006|85622059|56012099003|21082099003|18002099003|16102099003|15450700066; X-Microsoft-Antispam-Message-Info: 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 X-Forefront-Antispam-Report: CIP:194.37.82.176;CTRY:GB;LANG:en;SCL:1;SRV:;IPV:CAL;SFV:NSPM;H:Kar19569723.onmicrosoft.com;PTR:InfoDomainNonexistent;CAT:NONE;SFS:(13230040)(36860700016)(4022899009)(7149299003)(82310400026)(1032899013)(34070700014)(69100299015)(48200799018)(61400799027)(376014)(7049299003)(3109299003)(3122999024)(8096899003)(2066899003)(4076899003)(52005299006)(85622059)(56012099003)(21082099003)(18002099003)(16102099003)(15450700066);DIR:OUT;SFP:1501; X-MS-Exchange-AntiSpam-MessageData-ChunkCount: 1 X-MS-Exchange-AntiSpam-MessageData-0: OG7ShrQyQNWGCPR6MI1SxuLPAvFh7SkMlshopUu1TEyk4j2olVyref8xq/MsM/Yik+sKN4N40LfptWoaHpjCUtN+3o0YJwZXLMZ7pFl53XQxFPzYbdEBTlpdQ3c7xpWQ31rafYF0cQtoP8a1WF/g4s7ghqgIBJ/p2dQn2P5n52xW4f293kaRuLj5dM2Apd8+Rmko8bGLTcpaM1WReQOAPp6o5g5bgTxcuZhSpvobbLLePYRsvC6fl0k7zdhri3P23wZRgY20JmO+XHLVDoK6hcIvk/PE8cQtEMcbr0FfjE9IaVfohdye9CfBJ0VABgZGn0FhR1BASkFo0Cle16LZYSk6/Hi5u86qj/ABxodoXQo2tua/Now2aoqhd19e09vjjB5msfAbtXapbdO6xMSITZckFWklcwgEmh3ChU/WTtMe+2/Q/WjJGZxZYxIA9kCu X-OriginatorOrg: Kar19569723.onmicrosoft.com X-MS-Exchange-CrossTenant-OriginalArrivalTime: 24 May 2026 12:25:23.4699 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 378a4fec-0fce-4e95-f4d5-08deb98f879e X-MS-Exchange-CrossTenant-Id: b8ecd3c3-c68f-4bfd-9bf7-9219ebe37aba X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=b8ecd3c3-c68f-4bfd-9bf7-9219ebe37aba;Ip=[194.37.82.176];Helo=[Kar19569723.onmicrosoft.com] X-MS-Exchange-CrossTenant-AuthSource: TY2PEPF0000AB83.apcprd03.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem X-MS-Exchange-Transport-CrossTenantHeadersStamped: SEL0PFFFAECFF5E X-Greylist: Sender IP whitelisted by DNSRBL, not delayed by milter-greylist-4.6.2 (obelix.imp.ch [0.0.0.0]); Sun, 24 May 2026 14:25:30 +0200 (CEST) X-MS-Exchange-Organization-SCL: 0 X-Spam-Score: -1.15 BAYES_00,DKIM_ADSP_NXDOMAIN,FREEMAIL_FORGED_FROMDOMAIN,FREEMAIL_FROM,HEADER_FROM_DIFFERENT_DOMAINS,HTML_MESSAGE,MIME_HTML_ONLY,RCVD_IN_SWINOG_WHITE,SPF_HELO_PASS,SPF_PASS X-Scanned-By: MIMEDefang 2.84 on 127.0.1.1
<!DOCTYPE html
PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<title>Special Health Investigation</title>
<style type="text/css">
body {
font-family: 'Times New Roman', Times, serif;
background-color: #000000;
margin: 0;
padding: 0;
}
.main-table {
width: 100%;
max-width: 600px;
background-color: #ffffff;
margin: 0 auto;
}
.red-text {
color: #cc0000;
font-weight: bold;
}
.cta-button {
background-color: #cc0000;
color: #ffffff;
padding: 16px 28px;
font-family: Helvetica, Arial, sans-serif;
font-weight: bold;
text-decoration: none;
font-size: 18px;
border-radius: 3px;
display: block;
width: fit-content;
margin: 0 auto;
}
</style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="100%">
<tr>
<td align="center" style="padding: 20px 0;">
<table class="main-table" cellpadding="0" cellspacing="0" border="0">
<!-- HEADER -->
<tr>
<td style="background-color: #000000; padding: 20px; border-bottom: 4px solid #cc0000;">
<table width="100%">
<tr>
<td align="left"
style="color: #ffffff; font-family: Helvetica, Arial, sans-serif; font-size: 24px; font-weight: bold;">
HEALTH WATCH
</td>
<td align="right"
style="color: #cc0000; font-family: Helvetica, Arial, sans-serif; font-weight: bold;">
SPECIAL REPORT
</td>
</tr>
</table>
</td>
</tr>
<!-- CONTENT -->
<tr>
<td style="padding: 30px;">
<h1
style="font-family: Helvetica, Arial, sans-serif; font-size: 30px; line-height: 1.2; margin-top: 0; color: #111;">
<span class="red-text">Blood Sugar Breakthrough?</span>
Thousands Are Watching This Controversial Video...
</h1>
<div
style="font-family: Helvetica, Arial, sans-serif; font-size: 14px; color: #666; margin-bottom: 20px;">
By <strong>Dr. Michael Reeves</strong> | Medical Correspondent
</div>
<!-- VIDEO IMAGE -->
<a href="https://falokiju.blogspot.com/#4HswVR2984FUdO325cfttzstdyy7820RUFRXZZQACXTRGR591016SUUC1100975W8"
style="text-decoration: none; display: block; margin-bottom: 25px;">
<div style="border: 1px solid #ddd; padding: 5px;">
<!-- IMAGE -->
<div style="position:relative;">
<img src="https://images.unsplash.com/photo-1576091160399-112ba8d25d1d?auto=format&fit=crop&w=1200&q=80"
width="100%"
style="display:block;"
alt="Blood sugar health">
<!-- PLAY BUTTON -->
<div style="position:absolute;top:50%;left:50%;transform:translate(-50%,-50%);">
<div style="width:90px;height:90px;border-radius:50%;background-color:rgba(204,0,0,0.5);text-align:center;line-height:90px;font-size:42px;color:#ffffff;font-weight:bold;box-shadow:0 0 25px rgba(0,0,0,0.45);">
â¶
</div>
</div>
</div>
<!-- CTA BAR -->
<div
style="background-color:#cc0000;color:#ffffff;padding:12px;text-align:center;font-family:Helvetica, Arial, sans-serif;font-weight:bold;font-size:16px;text-transform:uppercase;">
Click To Watch The Video
</div>
</div>
</a>
<!-- ARTICLE COPY -->
<p
style="font-family: Georgia, 'Times New Roman', serif; font-size: 18px; line-height: 1.6; color: #333;">
<strong>(Atlanta, GA) â</strong>
A strange "blood sugar support" presentation is rapidly gaining attention after viewers claimed it helped improve daily energy, cravings, and glucose balance naturally.
</p>
<p
style="font-family: Georgia, 'Times New Roman', serif; font-size: 18px; line-height: 1.6; color: #333;">
Experts say these new <strong>GLPro Blood Sugar Capsules</strong>
may help support healthy blood sugar levels and metabolic function without extreme dieting.
</p>
<p
style="font-family: Georgia, 'Times New Roman', serif; font-size: 18px; line-height: 1.6; color: #333;">
<em>
"I started feeling more balanced within weeks. Less fatigue, fewer crashes, and my morning readings finally started improving."
</em>
says Linda M., one of the viewers featured in the report.
</p>
<!-- PRODUCT IMAGE -->
<div style="text-align:center;padding:10px 0 25px;">
<img src="https://i.8upload.com/image/bfcafb96aa81c5c0/glpro.png"
alt="GLPro Blood Sugar Capsules"
style="max-width:240px;display:inline-block;">
</div>
<!-- CTA -->
<br>
<a href="https://falokiju.blogspot.com/#4FNHqn2984MUYy325knfzvclpxe7820MWPZTKWYKLTIMLR591016JKSB1100975I8" class="cta-button">
WATCH: The GLPro Presentation â
</a>
</td>
</tr>
<!-- FOOTER -->
<tr>
<td
style="background-color:#f4f4f4;padding:20px;text-align:center;font-family:Helvetica, Arial, sans-serif;font-size:11px;color:#888;">
Sent by Health Watch Daily.<br>
<a href="https://falokiju.blogspot.com/#4mPCof2984rRFX325xvjoqgzucm7820QVUPINHBCUJPLLJ591016SSSN1100975r8">Unsubscribe</a> |
<a href="https://falokiju.blogspot.com/#4iissA2984Jwcp325xqkycggybu7820PYCGMXEOARVNFCQ591016ZYAB1100975C8">Terms of Service</a>
</td>
</tr>
</table>
</td>
</tr>
</table>
</body>
</html>